ARCHIVES

ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic.

This article is from The Cancer Letter archive.

Vol. 36 No. 13 | April 9, 2010

Download PDF Visit The Full Archive

Related Articles

Older Women More Likely To Receive Lower Chemotherapy Doses, Study Finds

August 28, 2009

NCA Declines To Set Minimum Comp Center Bed Number

April 2, 1976

AACR Using Its Clout To Urge Higher NCI Budget

May 24, 1991

New Protocol Could Improve Survival Of Rare Brain Tumor

October 30, 2009

Gene Therapy Shows Positive Results In Phase III Trial

July 25, 2008

Seffrin, Thomas Lead List of ACS Exec. VP Candidates, Reportedly

May 1, 1992